A complete guide to Hepatitis B, covering causes, symptoms, prevention, treatment, and the latest research in an easy-to-understand format.
Patient education — hepatitis B and D
Hepatitis B: A Comprehensive Guide for Patients
Hepatitis B affects more than 296 million people worldwide, across every continent and every socio-economic background. This guide takes the science of the virus — and of hepatitis D, which co-infects those already carrying it — and makes it usable by the people who need it most.
Authors
Prof. Seyed-Moayed Alavian, Dr. Seyede Hoda Alavian
Publisher
Publication year
2025
Print length
103 pages
Language
English
ISBN
978-90-8351-730-8
Audience
Patients, caregivers, healthcare professionals, and policymakers
Licence
CC BY-NC 4.0 (personal use)
Interested in this book?
Published by Brieflands and available for personal use under a CC BY-NC 4.0 licence. For copies, institutional orders, or commercial permissions, contact the publisher directly.
About this book
Hepatitis B is a pervasive and persistent global health challenge. It knows no borders, affecting people across all continents, ethnicities, and socio-economic backgrounds. The infection is chronic and transmitted primarily through blood and bodily fluids, and it can lead to complications that threaten life — cirrhosis and hepatocellular carcinoma among them. That burden is compounded by hepatitis D, a virus that co-infects or superinfects people already carrying hepatitis B, worsening outcomes and complicating treatment.
Despite advances in medicine, both remain under-addressed in much of the world. Limited awareness, restricted access to vaccination and treatment, and socio-economic disparity all sustain their spread. Sub-Saharan Africa, East Asia, and parts of the Middle East carry the heaviest burden, though no country is unaffected. Stigma compounds the problem by discouraging people from seeking timely diagnosis and care.
There has been real progress. Adding the hepatitis B vaccine to national immunisation programmes has sharply reduced new infections among children in many countries, and the World Health Organization has set the elimination of hepatitis B and C as public health threats by 2030. Meeting that goal requires broader public awareness, wider vaccination coverage, earlier diagnosis, effective antiviral therapy, and reliable surveillance.
This book was written to close the distance between medical expertise and public understanding: the science of the viruses and how they are transmitted, then prevention, management, and treatment. It is intended as a resource for patients and caregivers, and equally as a call to action for healthcare professionals and policymakers. The authors bring decades of experience in clinical hepatology, research, and public health advocacy to that task.
We dedicate this work to the millions living with hepatitis B and D, whose resilience inspires hope and progress.From the preface
What the book covers
The viruses
How hepatitis B and D work, and why co-infection changes the clinical picture.
Transmission
The routes by which infection spreads, and which are most common where.
Prevention
Vaccination, its role in national immunisation programmes, and other measures.
Diagnosis
Why early detection matters, and what testing involves.
Treatment
Antiviral therapy, long-term management, and monitoring for complications.
Stigma and elimination
The social barriers to care, and the WHO's 2030 elimination targets.
Important. This book provides education and does not replace clinical care. Chronic hepatitis B requires long-term specialist follow-up: not everyone needs antiviral treatment, but everyone diagnosed needs monitoring, including surveillance for liver cancer where indicated. Treatment should never be started or stopped without a hepatologist's advice, and household contacts should be tested and offered vaccination.